Hand stamping an “Approved” seal on a document, symbolizing regulatory authorization and compliance in healthcare or biotechnology.

Creative Medical Technology Holdings (NASDAQ: #CELZ) has received regulatory approval to advance its BioDefense Burn Pit Initiative, a capital-efficient, AI- and iPSC-driven biodefense program aimed at addressing long-term toxic exposure in U.S. veterans.
prismmarketview.com/creative-med...

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine and AI-enabled biodefense solutions, today announced that its BioDefense Inc. Burn Pit

#CELZ Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

www.stocktitan.net/news/CELZ/creative-medic...

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point Creative Medical Technology (NASDAQ: CELZ) announced on Dec 17, 2025 that it has completed patient enrollment in the FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel) for chronic lower back pain associated with degenerative disc disease. A prior independent DSMB safety review confirmed a favorable safety profile with no significant adverse events. With enrollment finished, the program moves to follow-up and data analysis as the company advances toward topline safety and efficacy readouts and late-stage development planning.

#CELZ Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

www.stocktitan.net/news/CELZ/creative-medic...

Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 Creative Medical (NASDAQ: CELZ) announced on Dec 2, 2025 that the World Health Organization approved olastrocel as the International Non‑Proprietary Name (INN) for the active cellular substance in its lead allogeneic cell therapy CELZ‑201 (AlloStem).The INN gives a globally standardized scientific name to the asset, aiding regulatory and clinical clarity, pharmacovigilance, labeling, and international development. Company leadership said the milestone supports global advancement and complements the program’s FDA Fast Track designation in degenerative disc disease. Olastrocel is being developed as an off‑the‑shelf perinatal‑tissue cell therapy for chronic lower back pain/DDD, new‑onset type 1 diabetes, and biodefense‑related indications.

#CELZ Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201

www.stocktitan.net/news/CELZ/creative-medic...

🚨 FeetrAI Alert: #CELZ is trading at $3.13 with low volume, hinting at limited investor interest. RSI is neutral, but MACD suggests bearish momentum. Consider a short at $3.12 with targets at $3.05 & $2.95. Stop loss at $3.25. Watch for volume spikes! 📉 #StockMarket #FeetrAI

🚨 FeetrAI Alert: #CELZ is trading at $3.12 with low liquidity and potential volatility! 📉 Bearish momentum as it sits below 20 & 30-day SMAs, with a negative MACD. Consider a SHORT at $3.15, targeting $3.00 & $2.85. Stop loss at $3.25. Stay alert for news! 📊 #Stocks #Trading

🚨 FeetrAI Alert: #CELZ is trading at $3.12 with a bearish setup! 📉 RSI at 45, MACD negative, and below key SMAs. EMA support at $3.11 could be a floor. Consider SHORT at $3.12, targeting $3.00 & $2.90. Stop loss at $3.20. Moderate confidence, watch closely! #Stocks #Trading

🚨 FeetrAI Alert: #CELZ is in the spotlight! Trading at $3.12, it's showing bearish momentum with a negative MACD and neutral RSI. Consider shorting around $3.15 with targets at $3.00 & $2.90. Stay sharp for any market shifts! 📉 #StockMarket #FeetrAI

🚨 FeetrAI Alert: #CELZ is in the spotlight! Trading at $3.135, it's showing bearish momentum with a negative MACD and downtrend in SMAs. Resistance at $3.20, support at $3.10. Consider shorting with targets at $3.05 & $2.95. Stop loss at $3.20. 📉 #StockMarket #FeetrAI

🚀 Exciting times for #CELZ! Trading at $3.115, it's showing a consolidation pattern with resistance at $3.20 and support at $3.00. Watch for a breakout above $3.20 to target $3.30-$3.40! 📈 Low volume & mixed signals suggest caution, but opportunities await! #FeetrAI #Stocks

🚀 Exciting times for #CELZ! Trading at $3.09, it's in a consolidation phase with potential support just above. Watch for a LONG play if it holds above $3.05, targeting $3.20 & $3.30. Stop loss at $2.95. Moderate confidence, but a market bounce could spark action! 📈 #FeetrAI

🚀 Exciting times for #CELZ! With a breakthrough in regenerative medicine, this stock is poised for a bullish move. Technicals show mixed signals, but with an entry at $3.10, targets at $3.30 & $3.50 are in sight. Keep an eye on developments and trade smart! 📈 #FeetrAI

🚀 Exciting times for #CELZ! With FDA approval boosting confidence, this healthcare stock is primed for a potential bullish move. Current price: $3.11, supported by a 10-day SMA of $3.02. Targeting $3.30 & $3.50 with a stop loss at $2.95. Watch for volume spikes! 📈 #FeetrAI

🚀 Exciting times for #CELZ! A breakthrough in regenerative medicine tech could spark upward momentum. Trading at $3.11, with a cautious long position advised. Target: $3.30-$3.50, stop loss at $2.90. Stay alert for updates! 📈 #FeetrAI #StockMarket #InvestSmart

🚨 FeetrAI Alert: #CELZ is trading at $3.10 with low liquidity and mixed signals! RSI is neutral, but MACD shows bearish momentum. Trading below key SMAs, expect resistance. Consider a SHORT position targeting $3.00 & $2.90, stop loss at $3.20. 📉 #StockMarket #FeetrAI

🚀 Exciting times for #CELZ! Trading at $3.11, it's showing mixed signals with low liquidity and potential volatility. Watch for a breakout above $3.20 with volume for a LONG play, targeting $3.30-$3.40. Stay alert for catalysts! 📈 #StockMarket #FeetrAI

🚀 Big news from Creative Medical Technology Holdings! #CELZ announces a breakthrough in regenerative medicine. Trading at $3.11, with mixed signals but potential for a bullish run. Consider entering at $3.10, targeting $3.30 & $3.50. Stop loss: $2.90. 📈 #InvestSmart

🚨 FeetrAI Alert: #CELZ is trading at $3.11 with low volume, hinting at limited investor interest. RSI is neutral, but MACD shows bearish momentum. Consider a SHORT at $3.15, targeting $3.00 & $2.90. Watch for volume spikes or news! 📉 #StockMarket #FeetrAI

🚀 Exciting insights from FeetrAI on #CELZ! Trading at $3.10, it's showing mixed signals with potential support at the 10-day SMA. Watch for sideways movement, but keep an eye on unexpected news! Entry: $3.05, Targets: $3.25/$3.40, Stop: $2.90. 📈 #StockMarket #FeetrAI

🚀 Exciting times for #CELZ! Trading at $3.10, it's showing mixed signals: 10-day SMA hints at a short-term rise, but MACD is bearish. RSI is neutral, and low volume suggests limited volatility. Consider a cautious long position with targets at $3.20 & $3.30. 📈 #FeetrAI

🚨 Bearish Alert on #CELZ! Trading at $3.10, Creative Medical Tech shows declining momentum with MACD & RSI signaling a downtrend. 📉 Low volume & sentiment suggest limited interest. Consider SHORT at $3.10, targeting $2.90 & $2.75. Stop loss: $3.25. #FeetrAI #StockAnalysis

🚨 FeetrAI Alert: #CELZ is at a crossroads! Trading at $3.10, it's caught between short-term support and potential resistance. With bearish MACD signals and low volume, a SHORT play could be strategic. Target: $2.90/$2.75, Stop: $3.25. 📉 #StockMarket #FeetrAI

🚀 Exciting times for #CELZ! Trading at $3.10, this stock is buzzing with increased volume and short-term support. Keep an eye on FDA news or partnerships for big moves! Consider a cautious long position with targets at $3.25 & $3.40. 📈 #FeetrAI #StockWatch

🚨 FeetrAI Alert: #CELZ is trading at $3.10 with low liquidity and mixed signals! 📉 Bearish MACD divergence suggests caution. Consider a short position at $3.15, targeting $2.90 & $2.75, with a stop loss at $3.25. FDA news could shake things up! #StockMarket #FeetrAI

🚨 FeetrAI Alert: #CELZ is showing bearish momentum with low volume! 📉 Trading at $2.925, it's facing resistance at $3.00 and support at $2.90. Consider a short position with targets at $2.85 & $2.75. Stay sharp for any news that could shake things up! #StockMarket #TradingTips

🚨 FeetrAI Alert: #CELZ is trading at $2.925 with bearish momentum! 📉 RSI & MACD hint oversold conditions, consolidating between $2.90-$3.00. Watch for a break below $2.91 for potential short to $2.80/$2.70. Stop loss at $3.05. Low volume, so stay alert for news! 📊 #Stocks

🚀 Exciting times for #CELZ! Trading at $2.925, it's oversold with potential for a short-term bounce. Watch for resistance at $3.00 and support at $2.90. Entry at $2.92 could target $3.00-$3.10. Cautious optimism advised—let's see if it breaks through! 📈 #FeetrAI

🚨 Bearish vibes for #CELZ! Trading at $2.925 with low volume, it's below key EMAs and RSI signals oversold conditions. MACD is negative, reinforcing the downtrend. Consider shorting at $2.95 with targets at $2.85 & $2.75. Stop loss: $3.05. 📉 #FeetrAI #StockAnalysis

🚨 FeetrAI Alert: #CELZ is trading at $2.925 with bearish momentum! 📉 Low volume and oversold RSI suggest a potential short opportunity. Consider entering at $2.93, targeting $2.80 & $2.70, with a stop loss at $3.05. Confidence is moderate—watch for catalysts! #Stocks #TradingTips

🚨 FeetrAI Alert: #CELZ is on a bearish path! Trading at $3.11, it's showing weak momentum with low volume and negative MACD. Consider a SHORT position with targets at $3.00 & $2.90. Stop loss at $3.25. Stay cautious and watch for any surprises! 📉 #StockMarket #FeetrAI